Recent studies demonstrated that uninterrupted dabigatran, but not factor Xa inhibitors, decreased the incidence of major bleeding during the periprocedural period of AF ablation when compared to uninterrupted VKA. This evidence concerns the gene F10 and atrial fibrillation.